Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
2,850,581
-
Number of holders
-
11
-
Total 13F shares, excl. options
-
734,994
-
Shares change
-
-456,612
-
Total reported value, excl. options
-
$800,000
-
Value change
-
-$2,001,575
-
Number of buys
-
7
-
Number of sells
-
-5
-
Price
-
$1.08
Significant Holders of Sunshine Biopharma Inc. - Common Stock, $0.001 par value (SBFM) as of Q2 2022
17 filings reported holding SBFM - Sunshine Biopharma Inc. - Common Stock, $0.001 par value as of Q2 2022.
Sunshine Biopharma Inc. - Common Stock, $0.001 par value (SBFM) has 11 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 734,994 shares
of 2,850,581 outstanding shares and own 25.78% of the company stock.
Largest 10 shareholders include BRIDGEWAY CAPITAL MANAGEMENT, LLC (568,400 shares), Virtu Financial LLC (47,861 shares), BANK OF MONTREAL /CAN/ (31,000 shares), TWO SIGMA SECURITIES, LLC (20,722 shares), GEODE CAPITAL MANAGEMENT, LLC (20,179 shares), Dakota Wealth Management (20,000 shares), Tower Research Capital LLC (TRC) (8,128 shares), ADVISOR GROUP HOLDINGS, INC. (7,465 shares), MORGAN STANLEY (6,867 shares), and BANK OF AMERICA CORP /DE/ (3,330 shares).
This table shows the top 11 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.